Alendronate sodium is an amino bisphosphonate bone resorption inhibitor, and intraosseous hydroxyapatite has a strong affinity, can enter the bone matrix hydroxyapatite crystals, when osteoclasts lyse crystals, the drug is released, can inhibit osteoclast activity, and indirectly inhibit bone resorption through osteoblasts, with strong anti-bone resorption activity, no bone mineralization inhibition characteristics. Alendronate sodium is used to treat postmenopausal osteoporosis and senile osteoporosis, osteoporosis, ectopic ossification, such as Paget's disease, deforming osteitis, kidney stones, malignant hypercalcemia, etc.
Alendronate sodium is the most widely used anti-osteoporosis drug in the world. It can significantly increase the bone density of patients, reduce the risk of fractures, and is a first-line treatment for osteoporosis.
|Appearance||The white or off-white crystalline powder||White crystalline powder|
|Phosphate and phosphite||≤0.5%||0.27%|
|Loss on drying||16.1-17.1%||16.9%|
|Heavy metal||≤10 ppm||Conforms|
|Appearance:||White crystalline powder|
|Package details:||1kg/ foil bag; 25kg/drum|
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!